[REPL]

Mid 2026-07-31 12:07:52

Replimune surges on positive AdCom vote on lead drug

Mid 2026-06-30 17:54:57

BMO upgrades Replimune stock rating on FDA filing progress

Row 2026-06-29 21:10:30

Replimune Group GAAP EPS of -$3.38 misses by $0.02